MicroRNA-management of lipoprotein homeostasis.
作者信息
Sun Xinghui, Feinberg Mark W
机构信息
From the Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
出版信息
Circ Res. 2014 Jun 20;115(1):2-6. doi: 10.1161/CIRCRESAHA.114.304228.
Abstract
摘要
相似文献
1
MicroRNA-management of lipoprotein homeostasis.
Circ Res. 2014 Jun 20;115(1):2-6. doi: 10.1161/CIRCRESAHA.114.304228.
2
Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33.
Circ Res. 2014 Jun 20;115(1):10-22. doi: 10.1161/CIRCRESAHA.115.303100. Epub 2014 Apr 21.
3
Activation of microRNA-378a-3p biogenesis promotes hepatic secretion of VLDL and hyperlipidemia by modulating ApoB100-Sortilin1 axis.
Theranostics. 2020 Mar 4;10(9):3952-3966. doi: 10.7150/thno.39578. eCollection 2020.
4
Influence of lipoprotein lipase and hepatic lipase on the transformation of VLDL and HDL during lipolysis of VLDL.
Atherosclerosis. 1995 Dec;118(2):193-212. doi: 10.1016/0021-9150(95)05606-8.
5
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides.
Nature. 2011 Oct 19;478(7369):404-7. doi: 10.1038/nature10486.
6
The effect of cholestyramine on lipoprotein lipids in patients with primary type IIA hyperlipoproteinemia.
Atherosclerosis. 1979 Jul;33(3):295-300. doi: 10.1016/0021-9150(79)90181-3.
7
Metabolism of esterified cholesterol in the plasma very low density lipoproteins of the rabbit.
Atherosclerosis. 1978 Nov;31(3):355-64. doi: 10.1016/0021-9150(78)90070-9.
8
Vitamin D3 uptake by the isolated perfused rat liver from lipoprotein fractions is separate from cholesterol and triglyceride uptake.
Eur J Clin Invest. 1985 Apr;15(2):95-9. doi: 10.1111/j.1365-2362.1985.tb00151.x.
9
The transport of triglyceride in the high-density lipoproteins of human plasma.
J Lab Clin Med. 1975 Feb;85(2):260-72.
10
Hepatocyte damage induced by carbon tetrachloride: inhibited lipoprotein secretion and changed lipoprotein composition.
Z Naturforsch C J Biosci. 2001 Mar-Apr;56(3-4):283-90. doi: 10.1515/znc-2001-3-419.
引用本文的文献
1
MicroRNAs as immune regulators and biomarkers in tuberculosis.
Front Immunol. 2022 Oct 27;13:1027472. doi: 10.3389/fimmu.2022.1027472. eCollection 2022.
2
MicroRNAs as Regulators of Cancer Cell Energy Metabolism.
J Pers Med. 2022 Aug 18;12(8):1329. doi: 10.3390/jpm12081329.
3
Noncoding RNAs in Nonalcoholic Fatty Liver Disease: Potential Diagnosis and Prognosis Biomarkers.
Dis Markers. 2020 Aug 27;2020:8822859. doi: 10.1155/2020/8822859. eCollection 2020.
4
MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease.
Molecules. 2019 Jan 9;24(2):230. doi: 10.3390/molecules24020230.
5
High-Density Lipoprotein Function in Cardiovascular Disease and Diabetes Mellitus.
Arterioscler Thromb Vasc Biol. 2018 Feb;38(2):e10-e16. doi: 10.1161/ATVBAHA.117.310222.
6
MicroRNAs 33, 122, and 208: a potential novel targets in the treatment of obesity, diabetes, and heart-related diseases.
J Physiol Biochem. 2017 May;73(2):307-314. doi: 10.1007/s13105-016-0543-z. Epub 2016 Dec 14.
7
miRNA Targeting of Oxysterol-Binding Protein-Like 6 Regulates Cholesterol Trafficking and Efflux.
Arterioscler Thromb Vasc Biol. 2016 May;36(5):942-951. doi: 10.1161/ATVBAHA.116.307282. Epub 2016 Mar 3.
8
Emerging role of microRNAs in lipid metabolism.
Acta Pharm Sin B. 2015 Mar;5(2):145-50. doi: 10.1016/j.apsb.2015.01.002. Epub 2015 Feb 24.
9
miRNAs in atherosclerotic plaque initiation, progression, and rupture.
Trends Mol Med. 2015 May;21(5):307-18. doi: 10.1016/j.molmed.2015.02.003. Epub 2015 Mar 11.
10
Expression profiling of preadipocyte microRNAs by deep sequencing on chicken lines divergently selected for abdominal fatness.
PLoS One. 2015 Feb 12;10(2):e0117843. doi: 10.1371/journal.pone.0117843. eCollection 2015.
本文引用的文献
1
Control of very low-density lipoprotein secretion by N-ethylmaleimide-sensitive factor and miR-33.
Circ Res. 2014 Jun 20;115(1):10-22. doi: 10.1161/CIRCRESAHA.115.303100. Epub 2014 Apr 21.
2
HDL-transferred microRNA-223 regulates ICAM-1 expression in endothelial cells.
Nat Commun. 2014 Feb 28;5:3292. doi: 10.1038/ncomms4292.
3
High-density lipoprotein and atherosclerosis regression: evidence from preclinical and clinical studies.
Circ Res. 2014 Jan 3;114(1):205-13. doi: 10.1161/CIRCRESAHA.114.300760.
4
Novel therapies focused on the high-density lipoprotein particle.
Circ Res. 2014 Jan 3;114(1):193-204. doi: 10.1161/CIRCRESAHA.114.301804.
5
MicroRNA control of high-density lipoprotein metabolism and function.
Circ Res. 2014 Jan 3;114(1):183-92. doi: 10.1161/CIRCRESAHA.114.300645.
6
Regulation of high-density lipoprotein metabolism.
Circ Res. 2014 Jan 3;114(1):143-56. doi: 10.1161/CIRCRESAHA.114.300632.
7
Heart disease and stroke statistics--2014 update: a report from the American Heart Association.
Circulation. 2014 Jan 21;129(3):e28-e292. doi: 10.1161/01.cir.0000441139.02102.80. Epub 2013 Dec 18.
8
MicroRNA-33 regulates sterol regulatory element-binding protein 1 expression in mice.
Nat Commun. 2013;4:2883. doi: 10.1038/ncomms3883.
9
Pharmacological inhibition of a microRNA family in nonhuman primates by a seed-targeting 8-mer antimiR.
Sci Transl Med. 2013 Nov 20;5(212):212ra162. doi: 10.1126/scitranslmed.3006840.
10
MicroRNA 33 regulates glucose metabolism.
Mol Cell Biol. 2013 Aug;33(15):2891-902. doi: 10.1128/MCB.00016-13. Epub 2013 May 28.
Zotero 插件